The apolipoprotein E ε4 allele is not associated with psychiatric symptoms or extrapyramidal signs in probable Alzheimer's disease

Neurology

Volumn 49, Issue 3, 1997, Pages 794-797

  Lopez, Oscar L ^a   Kamboh, M I ^b   Becker, J T ^b   Kaufer, D I ^b   DeKosky, S T ^b  

^a Neuropsychological Research Program   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALLELE; ALZHEIMER DISEASE; ARTICLE; DEPRESSION; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; ONSET AGE; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; AGED; EXTRAPYRAMIDAL SYNDROME; GENETICS; MENTAL DISEASE; PSYCHOLOGICAL RATING SCALE; RISK FACTOR;

AGE OF ONSET; AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BASAL GANGLIA DISEASES; FEMALE; HUMANS; MALE; MENTAL DISORDERS; NEUROLOGIC EXAMINATION; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS;

EID: 0030612459     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.3.794     Document Type: Article

References (32)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to beta-amyloid and increase frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:1997-1981.
2. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 and the risk of Alzheimer's disease. Science 1993;261:921-931.
3. Saunders AM, Hulette O, Welsh-Bohmer KA, et al. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 1996;348:90-93.
4. Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med 1995;331:1242-1247.
5. Soininen H, Kosumen O, Helisami S, et al. A severe loss of choline acetyl transferase in the frontal cortex of Alzheimer patients carrying apolipoprotein ∈4. Neurosci Lett 1995;187: 79-82.
6. Lehtovirta M, Soininen H, Laakso MP, et al. SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E ∈4 allele. J Neurol Neurosurg Psychiatry 1996;60:644-649.
7. Zubenko GS, Moossy J. Major depression in primary dementia: clinical and neuropathological correlates. Arch Neurol 1988;45:1182-1186.
8. Zubenko GS, Moossy J, Martinez AJ, Rao G, Claassen D, Kopp, U. Neuropathological and neurochemical correlates of psychosis in primary dementia. Arch Neurol 1991;48:619-624.
9. Förstl H, Burns A, Levy R, Cairns N. Neuropathological correlates of psychotic phenomena in confirmed Alzheimer's disease. Br J Psychiatry 1994;165:53-59.
10. Cummings J, Kaufer DI. Neuropsychiatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited. Neurology 1996;47:876-883.
11. Lopez OL, Kaufer DI, Reiter C, Carra J, DeKosky ST, Palmer AA. Relationship between CSF neurotransmitter metabolites and aggressive behavior in Alzheimer's disease. Eur J Neurol 1996;3:153-155.
12. Ramachandran G, Marder K, Tang M, et al. A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology 1996;47:256-259.
13. Lyketsos CG, Baker L, Warren A, et al. Depression, delusions, and hallucinations in Alzheimer's disease. No relationship to apolipoprotein E genotype. J Neuropsychiatry Clin Neurosci 1997;9:64-67.
14. Gearing M, Schneider JA, Rebek GW, Hyman BT, Mirra SS. Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. Neurology 1995;45:1985-1990.
15. Lippa CF, Smith TW, Saunders AM, et al. Apolipoprotein E genotype and Lewy body disease. Neurology 1995;45:97-103.
16. Olichney JM, Hansen LA, Galasko D, et al. The apolipoprotein E4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1996;47:190-196.
17. Letohvirta M, Soininen H, Helisalmi S, et al. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology 1996;46:413-419.
18. McKhann G, Drachman D, Folstein MF, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
19. Becker JT, Boller F, Saxton J, McGonigle K. The natural history of Alzheimer's disease. Arch Neurol 1994;51:585-594.
20. Hachinski VC, Iliff LD, Zihka E, et al. Cerebral blood flow in dementia. Arch Neurol 1974;32:632-637.
21. Kamboh MI, Aston CE, Hamman RF. The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis 1995;112:145-159.
22. Corder EH, Saunders AM, Rish NJ, et al. Protective effect of apolipoprotein E type 2 for late onset Alzheimer's disease. Nat Genet 1994;7:180-184.
23. Mezzich JE, Dow JT, Cottman GA. Developing an information system for a comprehensive psychiatric institute. I. Principles, design, and organization. Behav Res Methods Instrument 1981;13:459-463.
24. American Psychiatric Association. Diagnostic and statistical manual on mental disorders. 3rd ed. Revised. Washington, DC: American Psychiatric Press, 1987.
25. Tariot PN, Mack JL, Patterson MB, et al. The Behavior Rating Scale for dementia of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry 1995;152: 1349-1357.
26. Lopez OL, Gonzalez MP, Becker JT, Reynolds CF, Sudilovsky A, DeKosky ST. Symptoms of depression and psychosis in Alzheimer's disease and frontotemporal dementia: exploration of underlying mechanisms. Neuropsychiat Neuropsychol Behav Neurol 1996;9:154-161.
27. Huff JF, Boller F, Lucchelli F, Queriera R, Beyer J, Belle S. The neurological examination in patients with probable Alzheimer's disease. Arch Neurol 1987;44:929-932.
28. Hoehm M, Yahr M. Parkinsonism, onset, progression, and mortality. Neurology 1967;17:126-131.
29. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
30. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasu TB, eds. Geriatric psychiatry: a handbook for psychiatrists and primary care physicians. New York: Grune & Stratton, 1976:77-121.
31. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile changes in the cerebral white matter of elderly subjects. Br J Psychiatry 1968;114:797-811.
32. Hamilton M. The development of a rating scale for primary depressive illness. Br J Soc Psychol 1967;44:929-932.